| Previous Close | 1.900 |
| Open | 0.000 |
| Bid | 0.000 x 0 |
| Ask | 0.000 x 0 |
| Day's Range | 0.000 - 0.000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 11,615 |
| Market Cap | 21.958M |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Nov 5, 2018 - Nov 9, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.00 |
MRI Interventions (MRIC) and CLS AB in Lund, Sweden, announced that the companies have signed an agreement granting MRI Interventions the exclusive right to distribute and sell CLS’s portfolio of products, including its TRANBERG® product line for high precision ablation, in the U.S. and Canada. This agreement includes interventional MR-guided procedures beyond the previously announced license agreement for spine and neurosurgery. “This is an exciting collaboration for MRI to execute on our four-pillar growth strategy,” commented Joe Burnett, President and CEO of MRI Interventions.
MRI Interventions, Inc. (MRIC) and Clinical Laserthermia Systems AB (NASDAQ FIRST NORTH:CLS B) today entered into a collaborative license and co-development agreement to provide next-generation navigation and laser ablation platforms for use in Spine and Neurosurgery. Under the terms of the agreement, CLS will provide an exclusive, worldwide license to current and future products and IP to MRI Interventions and will act as the exclusive manufacturer of those products. “This agreement is a truly exciting step towards execution of our four-pillar growth strategy,” commented Joe Burnett, President and CEO of MRI Interventions.
MRI Interventions, Inc. (MRIC) and Monteris Medical, Inc. today announced a collaborative co-development agreement to provide a next-generation head fixation frame for use in laser ablation neurosurgery. Under terms of the agreement, Monteris will provide a license to intellectual property (IP) and technical development to MRI Interventions, who will in turn develop a joint product including MRI Interventions’ design concepts and IP. MRI Interventions will also support Monteris with respect to FDA filings. “An important part of our four-pillar growth strategy is to partner with other device, biologics and drug companies to provide the best products and workflow possible to enable life-saving and life-altering therapies,” commented Chris Osswald, Portfolio Manager at MRI Interventions.
MRI Interventions, Inc. (MRIC), announced today that the company has repaid in full and retired $2.0 million in outstanding debt held by Brainlab AG which was set to mature on December 31, 2018. “We are pleased to have successfully restructured our debt positions without having to raise equity or incur significant financing fees in the process,” commented Joe Burnett, President and CEO. Building on the power of magnetic resonance imaging (“MRI”), MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain.
MRI Interventions, Inc. (MRIC), announced today that Chief Executive Officer Joe Burnett will present at the Sidoti & Co. 2018 Fall Conference on Thursday, September 27, 2018, at 3:15 pm Eastern Time. Building on the power of magnetic resonance imaging (“MRI”), MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The ClearPoint Neuro Navigation System, which has received 510(k) clearance and is CE marked, utilizes a hospital’s existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain.
IRVINE, Calif., Aug. 14, 2018-- MRI Interventions, Inc. today announced financial results for its second fiscal quarter ended June 30, 2018.. Total revenue for the second quarter was $1.65 million, which ...
NEW YORK, NY / ACCESSWIRE / August 14, 2018 / MRI Interventions, Inc. (OTCQB: MRIC ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 14, 2018 at 4:30 PM Eastern ...
IRVINE, Calif., Aug. 07, 2018-- MRI Interventions, Inc. announced that it will release financial results for its 2018 second quarter, which ended June 30, 2018, on Tuesday, August 14, 2018 after the market ...
LOS ANGELES, CA / ACCESSWIRE / May 22, 2018 / MRI Interventions, Inc. (OTCQB: MRIC), today announced that Chief Executive Officer Joe Burnett will present at the 8th annual LD Micro Invitational on Tuesday, ...
NEW YORK, NY / ACCESSWIRE / March 27, 2018 / MRI Interventions, Inc. (OTCQB: MRIC), today announced that Joe Burnett, CEO, will present at the MicroCap Conference on April 9th and 10th at the Essex House ...
NEW YORK, NY / ACCESSWIRE / March 15, 2018 / MRI Interventions, Inc. (OTCQB: MRIC ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 15, 2018, at 4:15 PM Eastern ...